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ABSTRACT
Background Neonates are at major risk of sepsis, but 
data on neonatal sepsis incidence are scarce. We aimed 
to assess the incidence and mortality of neonatal sepsis 
worldwide.
Methods We performed a systematic review and 
meta- analysis. 13 databases were searched for the 
period January 1979–May 2019, updating the search of 
a previous systematic review and extending it in order 
to increase data inputs from low- income and middle- 
income countries (LMICs). We included studies on the 
population- level neonatal sepsis incidence that used a 
clinical sepsis definition, such as the 2005 consensus 
definition, or relevant ICD codes. We performed a 
random- effects meta- analysis on neonatal sepsis 
incidence and mortality, stratified according to sepsis 
onset, birth weight, prematurity, study setting, WHO 
region and World Bank income level.
Results The search yielded 4737 publications, of which 
26 were included. They accounted for 2 797 879 live 
births and 29 608 sepsis cases in 14 countries, most of 
which were middle- income countries. Random- effects 
estimator for neonatal sepsis incidence in the overall 
time frame was 2824 (95% CI 1892 to 4194) cases 
per 100 000 live births, of which an estimated 17.6% 
9 (95% CI 10.3% to 28.6%) died. In the last decade 
(2009–2018), the incidence was 3930 (95% CI 1937 to 
7812) per 100 000 live births based on four studies from 
LMICs. In the overall time frame, estimated incidence 
and mortality was higher in early- onset than late- onset 
neonatal sepsis cases. There was substantial between- 
study heterogeneity in all analyses. Studies were at 
moderate to high risk of bias.
Conclusion Neonatal sepsis is common and often fatal. 
Its incidence remains unknown in most countries and 
existing studies show marked heterogeneity, indicating 
the need to increase the number of epidemiological 
studies, harmonise neonatal sepsis definitions and 
improve the quality of research in this field. This can help 
to design and implement targeted interventions, which 
are urgently needed to reduce the high incidence of 
neonatal sepsis worldwide.
INTRODUCTION
Sepsis is a dysregulated host response to infection 
leading to life- threatening organ dysfunction.1 
Although neonates are highly vulnerable to sepsis, 
incidence estimates for this age group are lacking 
from many countries.2 Recently, the Global Burden 
of Disease (GBD) Study 2016/2017 estimated 1.3 
(95% CI 0.8 to 2.3) million annual incident cases 
of neonatal sepsis worldwide,3 resulting in 203 000 
(95% CI 178 700 to 267 100) sepsis- attributable 
deaths.4 Neonates are disproportionately affected in 
low- income and middle- income countries (LMICs) 
with a high prevalence of infectious diseases5 and 
poor access to adequately equipped and staffed 
healthcare facilities.6 In sub- Saharan Africa alone, 
an estimated 5.3–8.7 million disability- adjusted life- 
years have been lost in 2014 due to neonatal sepsis 
and consecutive long- term morbidity.7 Neonatal 
sepsis has resulted in an estimated economic burden 
of up to US$469 billion in this region (2014 data).7
In a previous systematic review and meta- analysis, 
we compiled evidence on the burden of paedi-
atric sepsis including neonatal sepsis.2 Only eight 
studies that used a clinical definition of neonatal 
What is already known on this topic?
 ► The Global Burden of Disease (GBD) estimated 
1.3 million annual incident cases of neonatal 
sepsis and other infections (approximately 
937 cases per 100 000 live births) and 
203 000 sepsis- attributable neonatal deaths. 
However, important contributors to the burden 
of neonatal infection and sepsis, such as 
pneumonia, are not captured by this estimate 
based on the GBD definition.
 ► A previous systematic review identified only 
eight studies on neonatal sepsis incidence 
from five countries that used a clinical sepsis 
definition.
What this study adds?
 ► We found in 26 studies a pooled neonatal 
sepsis incidence of 2824 sepsis cases per 100 
000 live births (95% CI 1892 to 4194) and a 
mortality of 17.6% (95% CI 10.3% to 28.6%). 
Preterm and very low birthweight neonates 
were particularly affected, and there were 
considerable regional differences in incidence.
 ► Data are lacking from many countries, 
underlining the need for further epidemiological 
research to guide interventions that reduce 
neonatal incidence and mortality.
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sepsis could be identified, of which five studies originated from 
LMICs. We aimed to assess the global incidence and mortality 
of neonatal sepsis with a particular focus on LMICs by updating 
and extending this previous systematic review. Secondary objec-
tives were to compile data on underlying organisms and antimi-
crobial resistance, hospital length of stay and sepsis- attributable 
mortality.
METHODS
The protocol of this systematic review was registered in PROS-
PERO (CRD42020149085).
Search strategy and selection criteria
As starting point, we used the previously published systematic 
review on neonatal sepsis incidence.2 All studies included in this 
review were added to our search. We then searched 13 elec-
tronic databases: MEDLINE, Embase, LILACS, African Journals 
Online, OpenGREY, MedCarib, Index Medicus for the WHO 
Eastern Mediterranean, African, South East Asia and Western 
Pacific Regions, IndMed, Web of Science and WHOLIS. No 
language or publication restrictions were applied. We updated 
the search strategy from the previous systematic review.2 
Furthermore, we used a comprehensive search strategy that 
combined a list of sepsis terms with the individual names of 
LMICs suggested by the Cochrane Effective Practice and Organ-
isation of Care (EPOC)8 group to search for studies published 
between January 1979 and May 2019 (see online supplmental 
appendix 1). Moreover, we hand- searched reference lists of 
relevant publications. Studies were eligible for inclusion if they 
reported population- level incidence or prevalence of neonatal 
sepsis (neonatal sepsis cases per live births of the hospital 
or region in a defined time frame). Neonatal sepsis had to be 
defined according to the International Consensus Conference on 
Paediatric Sepsis Definitions,9 sepsis 1,10 sepsis 211 or sepsis 31 
or modified clinical criteria, such as clinical signs of neonatal 
sepsis (hypothermia, bradycardia and apnoea) in the presence of 
infection. Studies based on sepsis- relevant ICD-9/ICD-10 codes 
were also included. Since definitions varied widely, we accepted 
definitions of early- onset sepsis (EOS) as sepsis within the first 
2–7 days of life. Depending on the EOS definition in each study, 
late- onset sepsis (LOS) was defined as sepsis diagnosed from 3 
to 8 days until 28 days after birth, resulting in individual studies 
with no double counting, but in overlap between the defini-
tions of EOS and LOS. We excluded studies that solely reported 
culture- proven sepsis cases, incidence per hospital admissions, or 
used the definition of possible severe bacterial infections (PSBIs) 
instead of neonatal sepsis, since neonatal sepsis accounts for only 
one out of four cases of PSBI.12 We excluded studies limited to 
other subgroups of sepsis, pathogens or specific patient groups, 
and studies with a missing study methodology description.
Data compilation and risk of bias assessment
Abstracts and full texts were reviewed by two independent inves-
tigators (CF, FR, MT, RH and YS). Discrepancies were resolved 
by discussion. Non- English articles were assessed by native 
speakers with medical backgrounds. Data extraction items and 
strategies can be found in the online supplemental appendix. 
Pathogen and antibiotic resistance data were only considered 
from the year 2000 onwards. Authors were contacted to specify 
methods and to provide additional data. Studies that met the 
inclusion criteria were assessed for risk of bias by the Hoy tool.13
Statistical analyses
We categorised the studies by sepsis type (EOS, LOS and EOS/
LOS combined). For subgroup analyses, participants were 
stratified by birth weight into normal birth weight (≥2500 g), 
low birth weight (1500–2499 g) and very low birth weight 
(<1500 g) neonates, and by gestational age into preterm (<37 
weeks) and term neonates. Countries were categorised by WHO 
region and World Bank income level, and studies by community- 
based or hospital- based design and decade in which the study 
was conducted according to the start of their observation period 
(before 1989, 1989–1998, 1999–2008 and 2009–2018). We 
conducted meta- analyses of sepsis incidence per 100 000 live 
births, mortality per 100 sepsis cases and the proportion of 
culture- proven sepsis with 95% CI using the package ‘meta’ 
V.4.9.5 in R V.3.6.1 (online supplemental appendix 2). We 
calculated pooled estimates using a random- effects model with 
variance stabilising logit transformed proportions and estimated 
between- study variance τ² using the Sidik- Jonkman estimator. 
We used I² statistics to quantify statistical heterogeneity.
RESULTS
We identified 4737 records (figure 1); 250 studies underwent 
full- text screening; and 26 fulfilled the inclusion criteria.14–39
The entire study population comprised 2 797 879 live births 
in 14 countries and five WHO regions (online supplemental 
appendix eTable 1 and figure 2). Two studies originated from 
low- income countries, 20 from middle- income and four from 
high- income countries (HICs). Studies were mostly prospective 
(n=18/26). We included 21 cohort studies, 4 trials and 1 case–
control study. The majority were single- centre studies. Seven 
studies used a community- based design; 19 were hospital- based, 
including studies limited to neonatal intensive care units (NICUs) 
or studies with entire hospitals under observation. Studies were 
at moderate to high risk of bias (online supplemental appendix 
eTable 2).
Overall, 29 608 sepsis cases were identified. Sepsis definitions 
varied by diagnostic criteria and time intervals (online supple-
mental appendix Table e1).
Incidence of EOS/LOS combined was reported by 21 studies, 
of which 5 provided separate results for EOS and LOS. EOS and 
LOS were distinct subgroups in these studies with no overlap. 
The remaining five studies reported exclusively on EOS. If not 
stated otherwise, our results refer to studies that report on EOS/
LOS combined. Separate analyses for EOS or LOS are provided 
if the number of studies was sufficient.
We found a random- effects estimate of 2824 neonatal sepsis 
cases per 100 000 live births (95% CI 1892 to 4194) in the 
overall time frame (before 1989–2018), with a 2.6 times higher 
incidence of EOS (2469/100 000, 95% CI 1424 to 4250) than 
LOS (946/100 000, 95% CI 544 to 1642) (figure 3). For the past 
decade (2009–2018), the random- effects estimate for EOS/LOS 
incidence was 3930/100 000 (95% CI 1937 to 7812) based on 
four studies from LMICs. Compared with estimates from past 
decades, we found no clear temporal trends but wide CI for each 
epoch (1999–2008: 2706, 95% CI 1451 to 4993; 1989–1998: 
4012, 95% CI: 1808 to 8665; before 1989: 1250, 95% CI 534 
to 2896). Of note, studies included in each time stratum differed 
in terms of study design and country of origin. The estimated 
incidence of EOS for the decade until 2018 was 3112/100 
000 (95% CI 898 to 10 222) based on four studies (table 1). 
Only one study reported LOS incidence estimates from the past 
decade (investigators of Delhi Neonatal Infection Study (DeNIS) 
collaboration: 658, 95% CI 607 to 713, per 100 000).
Birth weight and gestational age were inversely related to 
EOS incidence, resulting in the highest incidence in VLBW (17 
129/100 000, 95% CI 9192 to 29 679) and preterm neonates 
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(10 252/100 000, 95% CI 7891 to 13 218) (online supplemental 
appendix eFigure 1).
Incidence estimates were higher in community- based studies 
(8549/100 000, 95% CI 5520 to 13 011) than in hospital- 
based studies (1986/100 000, 95% CI 1350 to 2914) (online 
supplemental appendix eFigure 2). Although the 95% CIs for 
each income stratum were overlapping, compared with HICs, 
neonatal sepsis incidence was 1.8- fold higher in middle- income 
countries and 3.5- fold higher in low- income countries (online 
supplemental appendix figure 3). Incidence was highest in 
studies from Africa (5244/100 000, 95% CI 2505 to 10 651; 
table 1).
We observed substantial heterogeneity between studies, even 
within subgroup analyses.
Overall, the random- effects estimate for neonatal sepsis case 
mortality was 17.6% (95% CI 10.3% to 28.6%), and 16.4% 
(95% CI 9.8 to 26.1) and 9.1% (95% CI 2.1 to 32.5) for EOS 
and LOS, respectively (online supplemental appendix figure 4). 
Again we observed substantial heterogeneity (I²≥90%). The 
investigators of DeNIS collaboration attributed 24% of neonatal 
deaths to sepsis.18
In total, 16 studies reported a proportion of culture- proven 
sepsis, resulting in a random- effects estimate of 31.8% (95% CI 
23.5% to 41.4%) for EOS/LOS combined (online supplemental 
appendix figure 5). For EOS, lower proportions were reported 
(11.4%, 95% CI 2.7 to 37.1%) based on six studies than for LOS 
(27.5%, 95% CI 8.9% to 59.5%) based on three studies. Most 
commonly identified pathogens were Staphylococcus aureus and 
Figure 1 Flow of study inclusion.
Figure 2 Number of studies on neonatal sepsis incidence (early- onset and late- onset sepsis combined) included per country.
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Klebsiella spp (online supplemental appendix table 3). Results 
on antimicrobial resistance, which was reported in 3 out of 16 
studies, are presented in online supplemental appendix table 3.
DISCUSSION
Our estimates confirm that neonatal sepsis is an important 
contributor to neonatal morbidity worldwide, with a higher 
burden in LMICs. Based on the available evidence of 26 studies 
from 14 countries, we found an incidence of 2824 neonatal 
sepsis cases per 100 000 live births in the overall time frame. 
Mortality was 17.6%. The incidence estimate was 1.4- fold 
higher in the past decade (2009–2018, 3930/100 000 live 
births), but this estimate was exclusively relying on LMIC data, 
which might be one reason for the higher incidence. No recent 
data from HIC could be identified, indicating gaps in epide-
miological research on neonatal sepsis all over the world. The 
overall incidence and mortality for neonatal sepsis was higher 
than the estimates for EOS and LOS. This could be explained 
by inclusion of different studies in the three meta- analyses. Inci-
dence of EOS was higher in risk groups, such as LBW, VLBW and 
preterm infants. In our analyses, the observed population- level 
incidence of neonatal sepsis was more than four times higher 
in community- based compared with hospital- based studies. This 
may reflect high rates of mothers delivering outside a health-
care facility without a skilled birth attendant, unsterile cord care 
practices, reduced access to healthcare facilities and lower care 
seeking behaviours40 in LMICs, where the included community- 
based studies originated from. On the other hand, hospitalisa-
tion, improved survival of preterm newborns and use of invasive 
devices increase the incidence of nosocomial LOS cases, espe-
cially in HIC.41 42
Our most recent results of neonatal sepsis incidence in the past 
decade (2009–2018) indicate an approximately four times higher 
number of global neonatal sepsis cases than the GBD estimates 
(3930 vs 937 cases per 100 000), likely due to different method-
ologies, such as varying case definitions, data collection methods 
Figure 3 Incidence of neonatal sepsis (EOS, late- onset sepsis, and EOS/LOS combined) per 100 000 live births by sepsis type. EOS, early- onset sepsis; 
LOS, late- onset sepsis.
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Table 1 Meta- analysis estimates and heterogeneity
Sepsis type Subgroup Incidence estimates (n)
MA: incidence
Random- effects estimates (cases per 100 000 live births) I² (%)
By date
EOS+LOS Before 1989 5 1250.0 (534.4 to 2895.7) 90.9
1989–1998 8 4012.4 (1808.5 to 8665.4) 99.9
1999–2008 8 2706.3 (1450.9 to 4993.0) 99.9
2009–2018 4 3930.4 (1936.9 to 7812.1) 98.1
EOS Before 1989 – – –
1989–1998 2 3476.0 (2841.9 to 4245.3) 84.5
1999–2008 6 1878.2 (863.7 to 4035.7) 98.0
2009–2018 4 3112.3 (898.2 to 10 222.1) 99.9
LOS Before 1989 – – –
1989–1998 2 Singe- study estimate: 718 (595.7 to 865.1) 0.0
1999–2008 4 1189.2 (458.0 to 3052.0) 99.0
2009–2018 1 Single- study estimate: 657.8 (606.6 to 713.2) –
By patient subgroup
EOS+LOS NBW 2 2430.1 (1164.4 to 5001.7) 92.5
LBW 2 7475.1 (5857.0 to 9495.1) 11.1
VLBW 1 Single- study estimate: 31 428.6 (18 335.2 to 48 337.7) –
Term 1 Single- study estimate: 3593.4 (3202.9 to 4029.5) –
Preterm 1 Single- study estimate: 13 592.2 (10 202.5 to 17 883.9) –
EOS NBW 3 818.1 (204.5 to 3213.9) 96.6
LBW 3 5421.5 (3706.5 to 7865.0) 76.8
VLBW 3 17 128.8 (9192.1 to 29 678.5) 74.7
Term 3 821.3 (200.5 to 3300.2) 97.1
Preterm 3 10 251.7 (7890.8 to 13 217.7) 57.2
LOS NBW 0 – –
LBW 1 Single- study estimate: 517.2 (166.9 to 1591.1) –
VLBW 1 Single- study estimate: 1388.9 (86.3 to 18 672.7) –
Term 0 – –
Preterm 1 Single- study estimate: 323.6 (45.6 to 2260.0) –
By WHO region
EOS+LOS AFR 3 5243.6 (2504.6 to 10 650.6) 95.5
PAR 6 1541.6 (613.5 to 3819.8) 99.9
SEAR 11 4005.1 (2438.5 to 6511.2) 99.4
EMR 2 585.5 (192.8 to 1764.1) 81.8
WPR 3 3573.9 (2570.8 to 4948.6) 95.5
EOS AFR 1 Single- study estimate: 3555.2 (3173.9 to 3980.4) –
PAR 1 Single- study estimate: 5029.0 (3852.2; 6540.9) –
SEAR 7 1991.8 (795.0 to 4901.0) 99.9
EMR 0 – –
WPR 3 2824.4(1843.9; 4303.6) 96.4
LOS   NA
By World Bank income level
EOS+LOS Low 2 6086.4 (1843.1 to 18 280.0) 97.8
Middle 16 3195.3 (1991.2 to 5089.7) 99.2
High 7 1722.3 (769.2 to 3810.7) 99.9
EOS Low 0 – –
Middle 9 2359.3 (1131.6 to 4853.6) 99.9
High 3 2824.4 (1843.9 to 4303.6) 96.4
LOS   NA
By study setting
EOS+LOS Community- based 6 8549.3 (5520.3; 13 011.5) 98.7
Hospital- based 19 1986.5 (1350.0 to 2914.1) 99.9
EOS Community- based 2 2187.2(44.6; 52 848.4) 99.8
Hospital- based 10 2518.7 (1792.1 to 3529.5) 98.5
LOS   NA
AFR, African Region; EMR, Eastern Mediterranean Region; EOS, early- onset sepsis; LBW, low birth weight; LOS, late- onset sepsis; MA, meta- analysis; NA, not applicable; NBW, normal birth weight; 
PAR, Region of the Americas; SEAR, South- East Asia Region; VLBW, very low birth weight; WPR, Western Pacific Region.
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and data inputs from different countries. Extrapolations from 
our findings must be interpreted with caution since the included 
studies may not be representative of the global population and 
carry a moderate to high risk of bias. Contrary to most studies 
that we included in our review, cases of pneumonia are captured 
in the GBD modelling of pneumonia as a separate entity, but 
not as neonatal sepsis cases,3 which is a major methodological 
difference. Furthermore, the GBD study used more recent data 
to compute estimates for the year 2017, while our most recent 
estimates refer to the past decade (2009–2018).3 The recent 
GBD study, which used another methodology to assess sepsis- 
associated deaths and hospital incidence of sepsis, estimated 
20.3 million incident sepsis cases in children aged <5 years per 
year.43 The authors did not present specific data on neonatal 
sepsis. However, given that neonates account for approximately 
two out of three sepsis cases in children aged <5 years,17 the 
estimated incidence is likely higher than those in previous GBD 
studies.
Approximately one- third of infections were culture- proven 
with S. aureus and Klebsiella spp as the most common causative 
pathogens. However, in most studies that reported aetiology, the 
assessments of causative pathogens were based on only a low 
number of isolates or originated from single- centre studies. A 
cautious interpretation of these results is therefore necessary, 
other systematic reviews with a scope on aetiology and antibiotic 
susceptibility could compile more evidence.44 45 Susceptibility 
testing results were reported too seldomly and may be outdated, 
and the data are too heterogeneous to draw conclusions.
The extended search strategy identified 17 additional studies 
from LMICs and 1 additional study from an HIC. In general, 
systematic reviews that lack information from LMICs may 
benefit from a broader search strategy but inclusion of specific 
LMIC country names, and filters for LMIC as proposed by the 
EPOC group. We included data from seven community- based 
studies that followed up a large number of newborns in partly 
rural regions by trained village health workers/teams and are of 
particular value to better understand the neonatal sepsis epide-
miology in remote and rural community settings in low- income 
countries.
Major knowledge gaps on the population- based epidemiology 
of neonatal sepsis remain in most countries, particularly, but 
not exclusively, in LMICs. Reasons for this may be the lack of 
a robust research infrastructure, formal healthcare systems46 or 
prioritisation of other important healthcare issues. Furthermore, 
several large observational studies that target severe neonatal 
infections did not meet our inclusion criteria either due of their 
scope or the inclusion criteria.
There are limitations of our study. First, the studies we 
included may not be representative of the global population for 
several reasons. Data inputs were from 14 countries from five 
WHO regions; thus information on the majority of countries and 
the European WHO region was not included. Numerous studies 
only reported the incidence of NICU- treated or hospital- treated 
neonatal sepsis, which may underestimate the incidence of 
neonatal sepsis by excluding diseased infants outside the hospital 
setting. This is of particular relevance in LMICs, where a consid-
erable number of births occur outside the hospital47 and health-
care seeking for sick neonates may be low.40 Furthermore, most 
hospital- based studies were performed in tertiary care hospitals, 
which deliver higher quality of care compared with community 
hospitals, where a large number of neonates may seek care in 
some contexts. Second, we cannot judge on temporal trends as 
the number of studies in the respective time strata was low. Thus, 
differences in incidence estimates depending on the years of 
observation may be also explained by the fact that studies origi-
nated from different regions and used study designs with limited 
comparability. Third, the included studies were at moderate to 
high risk of bias, mainly due to the aforementioned lack of repre-
sentativeness and a reliable case definition. Fourth, we observed 
high between- study heterogeneity, possibly due to differing 
study designs, settings and observation periods. The pooled esti-
mates include population- level estimates from community- based 
studies, as well as NICU- based and hospital- based studies from 
facilities of different levels of care. General access, capacities 
and admission policies may differ between NICUs and coun-
tries. Heterogeneity may also be driven by different definitions. 
Applied sepsis definitions are mostly adaptations of the clinical 
consensus criteria,9 such as when laboratory testing was unavail-
able,31 or relied on selected clinical symptoms of neonatal sepsis. 
Currently, there is no sepsis definition for the neonatal age group 
in line with the current sepsis definition,48 which can be applied 
in all resource settings and also in preterm neonates. That leads 
to wide variations of existing neonatal sepsis definitions49 and 
hampers the comparability of sepsis epidemiology studies. In our 
review, we accepted a wide range of definitions, including those 
based on clinical criteria, to not exclude studies from LMICs. 
We pooled estimates from all included studies to gather all avail-
able evidence on the epidemiology of neonatal sepsis. Fifth, the 
underlying causes of death in these neonates were not reported 
except in one of the included studies, which concluded a sepsis- 
attributable mortality rate of 24%. The remaining studies 
referred to the proportion of patients with neonatal sepsis who 
died, but the cause of death was not specified. Finally, while our 
systematic review and pooled estimates consider only live births, 
globally, one out of four stillbirths are attributed to infection,50 
adding substantially to the overall burden of perinatal deaths 
that are due to sepsis.
The limitations identified by our study highlight the need 
to increase and improve epidemiological research on neonatal 
sepsis. A crucial prerequisite is the establishment of a harmon-
ised definition and validated diagnostic criteria for neonatal 
sepsis applicable in all resource settings and in preterm 
neonates. Furthermore, a standardisation of study designs 
and reporting, for example, in line with the Strengthening 
the Reporting of Observational Studies in Epidemiology for 
Newborn Infection checklist, is important.51 Further invest-
ments in epidemiological research infrastructure and capacity 
in both LMICs and HICs are needed in order to improve 
surveillance of neonatal sepsis, particularly in community- 
based designs. Having robust methodologies to measure the 
burden of neonatal sepsis will be extremely useful to assess the 
effect of urgently needed interventions to prevent it. Indeed, a 
lot needs to be done yet to prevent infections in neonates and to 
reduce the frequency of their evolution to sepsis complications. 
The WHO issued recommendations on key prevention and 
control measures both in the community and hospital setting 
and improved early recognition and timely and appropriate 
treatment of neonatal sepsis, as well as recommendations for 
early essential newborn care.52–55 This includes, among others, 
exclusive breast feeding, skin- to- skin contact with the mother 
from birth, the empirical antibiotic treatment of neonates with 
signs of severe infection/sepsis (eg, fast breathing) and educa-
tion of families on the recognition of signs of neonatal sepsis 
by trained community health workers.54 55 Given that approx-
imately one quarter of neonatal deaths is related to infection 
and sepsis, progress in reducing the burden of neonatal sepsis 
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